Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Ana Gleisner and Kathryn Colborn.

 
Connection Strength
 
 
 
0.958
 
  1. Leonard LD, de Araujo TB, Quinn C, Thomas MB, Beaty L, Mott NM, Colborn K, Heelan AA, Tevis SEA, Christian N, Arhendt G, Gleisner AL. De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5692-5702.
    View in: PubMed
    Score: 0.226
  2. Leonard LD, Beaty L, Thomas M, Quinn C, Colborn KL, de Araujo TB, Torphy RJ, Assump??o LR, Olino K, Studts CR, Rodriguez Franco S, McCarter M, Stewart C, Gleisner AL. Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma. J Surg Oncol. 2023 Mar; 127(4):716-726.
    View in: PubMed
    Score: 0.217
  3. Gleisner AL, Moss A, Friedman C, Suresh K, Grunwald G, Torphy RJ, Leonard LD, Colborn K, Ahrendt G, Tevis S, Christian N, Abud VL, de Araujo TB, Beaty LE, Thieu D, Glorioso TJ, Kim S, Daugherty S. De-implementation of Axillary Dissection in Women With Breast Cancer is Largely Driven By Site-level Contextual Effects. Ann Surg. 2022 12 01; 276(6):e923-e931.
    View in: PubMed
    Score: 0.190
  4. Stuart CM, Kirsch MJ, Zhuang Y, Meguid CL, Sugawara T, Colborn KL, Messersmith W, Lieu C, Gleisner AL, Del Chiaro M, Schulick RD, Meguid RA. Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. Surgery. 2023 09; 174(3):654-659.
    View in: PubMed
    Score: 0.057
  5. Sugawara T, Rodriguez Franco S, Sherman S, Torphy RJ, Colborn K, Franklin O, Ishida J, Grandi S, Al-Musawi MH, Gleisner A, Schulick RD, Del Chiaro M. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study. Ann Surg. 2024 Feb 01; 279(2):331-339.
    View in: PubMed
    Score: 0.056
  6. Sugawara T, Rodriguez Franco S, Sherman S, Kirsch MJ, Colborn K, Ishida J, Grandi S, Al-Musawi MH, Gleisner A, Schulick RD, Del Chiaro M. Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. JAMA Oncol. 2023 03 01; 9(3):316-323.
    View in: PubMed
    Score: 0.055
  7. Sugawara T, Rodriguez Franco S, Kirsch MJ, Colborn KL, Ishida J, Grandi S, Al-Musawi MH, Gleisner A, Del Chiaro M, Schulick RD. Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine Tumors. JAMA Netw Open. 2023 03 01; 6(3):e234096.
    View in: PubMed
    Score: 0.055
  8. Oba A, Wu YHA, Colborn KL, Karam SD, Meguid C, Al-Musawi MH, Bao QR, Gleisner AL, Ahrendt S, Schulick RD, Del Chiaro M. Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis. Br J Surg. 2022 04 19; 109(5):450-454.
    View in: PubMed
    Score: 0.052
  9. Oba A, Wu YHA, Lieu CH, Meguid C, Colborn KL, Beaty L, Al-Musawi MH, Davis SL, Leal AD, Purcell T, King G, Wooten ES, Fujiwara Y, Goodman KA, Schefter T, Karam SD, Gleisner AL, Ahrendt S, Leong S, Messersmith WA, Schulick RD, Del Chiaro M. Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. Br J Surg. 2021 08 19; 108(8):976-982.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)